Ataxxa 1250 mg/250 mg spot-on solution for dogs over 10 kg up to 25 kg
Ataxxa 1250 mg/250 mg spot-on solution for dogs over 10 kg up to 25 kg
Authorised
- Permethrin
- Imidacloprid
Product identification
Medicine name:
Ataxxa 1250 mg/250 mg spot-on solution for dogs over 10 kg up to 25 kg
ATAXXA 1250 mg/250 mg SOLUCION PARA UNCION DORSAL PUNTUAL PARA PERROS DE MAS DE 10 kg HASTA 25 kg
Active substance:
- Permethrin
- Imidacloprid
Target species:
-
Dog
Route of administration:
-
Spot-on use
Product details
Active substance and strength:
-
Permethrin1250.00/milligram(s)1.00Pipette
-
Imidacloprid250.00/milligram(s)1.00Pipette
Pharmaceutical form:
-
Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AC54
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Available in:
-
Spain
Package description:
- White polypropylene pipette closed with a polyethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.6 ml pipette containing 2.5 ml of solutionBox containing 10 pipettes.
- White polypropylene pipette closed with a polyethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.6 ml pipette containing 2.5 ml of solutionBox containing 6 pipettes.
- White polypropylene pipette closed with a polyethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.6 ml pipette containing 2.5 ml of solutionBox containing 4 pipettes.
- White polypropylene pipette closed with a polyethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.6 ml pipette containing 2.5 ml of solutionBox containing 3 pipettes.
- White polypropylene pipette closed with a polyethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.6 ml pipette containing 2.5 ml of solutionBox containing 1 pipette.
- White polypropylene pipette closed with a polyoxymethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.6 ml pipette containing 2.5 ml of solutionBox containing 1 pipette.
- White polypropylene pipette closed with a polyoxymethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.6 ml pipette containing 2.5 ml of solutionBox containing 3 pipettes.
- White polypropylene pipette closed with a polyoxymethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.6 ml pipette containing 2.5 ml of solutionBox containing 4 pipettes.
- White polypropylene pipette closed with a polyoxymethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.6 ml pipette containing 2.5 ml of solutionBox containing 6 pipettes.
- White polypropylene pipette closed with a polyoxymethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.6 ml pipette containing 2.5 ml of solutionBox containing 10 pipettes.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- KRKA tovarna zdravil d.d. Novo mesto
- TAD Pharma GmbH
Responsible authority:
- Spanish Agency Of Medicines And Medical Devices
Authorisation number:
- 3328 ESP
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0439/003
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Czechia
-
Estonia
-
France
-
Germany
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 28/01/2022
Spanish (PDF)
Published on: 16/02/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 14/01/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 15/03/2023